4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-20-019787
President & CEO sold 47,017 shares at an average $87.75 ($4,125,906)
- President & CEO acquired 102,064 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Simon, Christopher · President & CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-12 | Grant or award : show line 1 in the form | +102,064 | 417,411 | D | ||
| 2020-06-12 | Sale : show line 2 in the form | −1,294 | $89.29 | $115,541 | 416,117 | D |
| 2020-06-15 | Sale : show line 3 in the form | −45,723 | $87.71 | $4,010,364 | 370,394 | D |
| Open-market sales · 47,017 sh · avg $87.75 · $4,125,906 | ||||||
Loading xslF345X03/form4.xml…